Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Neurosci.

Sec. Neuropharmacology

This article is part of the Research TopicNovel Pharmacological Interventions in Emotional and Neuropsychiatric DisordersView all 8 articles

Advancing Depression Treatment: The Role of Sigma Receptor Ligands

Provisionally accepted
  • 1Department of Anesthesiology, Air Force Hospital of Western Theater Command, PLA, Chengdu, China
  • 2Department of Anesthesiology and Perioperative Medicine, Xijing Hospital, The Fourth Military Medical University, Key Laboratory of Anesthesiology (FMMU), Ministry of Education, Xi'an, China

The final, formatted version of the article will be published soon.

Depression, one of the most prevalent neuropsychiatric disorders, continues to pose escalating global health challenges. Despite the discovery of numerous antidepressants, their clinical applications are limited, and there is still an urgent need to identify more effective antidepressant drugs and their molecular targets. In recent years, sigma receptors have garnered considerable interest among depression researchers because of their diverse biological functions and significant roles in the central nervous system. This review provides a comprehensive summary of the potential roles of sigma receptors and their ligands in the pathogenesis of depression and the course of antidepressant treatment, with the aim of offering insights into further research and potential therapeutic development.

Keywords: Sigma receptor, ligands, Depression, NMDA, LTP

Received: 25 Aug 2025; Accepted: 10 Nov 2025.

Copyright: © 2025 Zhang, Chen, Lu and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Fei Fei Xu, xufeifei0204@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.